LOS ANGELES, Jan 15 — Good news for senior felines hoping to get a spring back in their step.The US Food and Drug Administration on Thursday approved its first treatment to control pain associated with osteoarthritis in cats, which is also the first monoclonal antibody drug approved for any animal species.
Some that are approved for humans with cancer perform other functions, like tagging cancer cells so the immune system can recognize them better and fight them. Solensia, the new injectable drug approved for cats, works by attaching itself to a protein called nerve growth factor that is involved in the regulation of pain.
The condition is thought to affect 60 percent of cats aged six years and up, and 90 percent of cats older than 12. The owners were then asked to assess their cats’ response after receiving treatment. Overall, the cats in the treatment group had better assessment scores than those who received placebos during randomized clinical trials.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.